Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade

HIGHLIGHTS

• who: Ioannis A. Vathiotis from the Published in partnership with The Hormel Institute, University of Minnesota have published the Article: Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade, in the Journal: (JOURNAL)
• what: The authors provide proof of concept that different gene_expression profiles are associated with outcome at subsequent timepoints post treatment initiation. The models showed the highest accuracy for predicting clinical benefit at 24 months (LTB), with AUC values consistently over 0.8. To evaluate benefit following treatment with ICIs the authors show that conventional objective . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.